As demand for abortion pills grows, pro-choice advocates are hiding the risks from women

TThe increasing use of abortion pills poses another challenge for states looking to protect unborn children, and it poses a danger to women who are misled by the misleading marketing of the abortion industry.

A Guttmacher Institute
found that in 2020, for the first time, the abortion pill accounted for more than half of abortions in the United States, with 54% of the 930,000 abortions performed being caused by the pill.

The use of abortion pills increased during the COVID-19 pandemic when the FDA announced it would drop the requirement that abortion pills be administered in an in-person clinic under physician supervision, allowing women to access them remotely via telemedicine clinics and mail be able.

Several abortion pill start-up companies such as Choix, Hey Jane and Just the Pill have seen a surge in demand and funding over the past year
. Hey Jane CEO Kiki Freedman said the company has doubled its clinical team since Texas passed its heartbeat law in September and has seen a “nine-fold increase in new telemedicine patients per day” compared to last year.

“In a postroe Globally, mail-in abortion is likely to become the most viable form of access for most of the country,” Freedman said.

The abortion pill is actually two drugs, mifepristone and misoprostol, taken 24 to 48 hours apart. The first blocks progesterone, a hormone a baby needs to live and grow, and the second causes spasms to push the baby out of the womb.

Nineteen states
the physical presence of a doctor when administering the drug, according to the Guttmacher Institute. Legal disputes about this requirement are already pending. For example, in Mississippi, mifepristone manufacturer GenBioPro
Mississippi State Health Commissioner Thomas Dobbs on state restrictions requiring an in-person prescription. The federal judge handling the case said he was “not sure” at this time whether to move it all the way to the Supreme Court Dobbs decision approved.

Abortion providers promote the pill as safe, and it is recommended by a number of elite medical bodies, including the World Health Organization. But the possible side effects and consequences of this pill are not always shared. The FDA
26 deaths since 2000 and more than 4,000 adverse events, although other studies find this number understated.

A Charlotte Lozier Institute
to learn
used Medicaid data to analyze 17 years of chemical abortions and found a 500% increase in abortion-related emergency room visits after chemical abortions between 2002 and 2015. Of the 423,000 confirmed abortions, 121,283 followed within 30 days of emergency room visits, which means roughly 35 in 100 abortions resulted in a visit. Compared to surgical abortions, women who received a chemical abortion had a 22% greater risk of ending up in the emergency room for any reason.

Worse, 60% of abortion-related post-abortion pill visits were incorrectly coded as miscarriage treatment. Another study by the Charlotte Lozier Institute, published in
found that miscoding abortions as miscarriages puts women at risk of multiple hospitalizations.

That’s the danger posed by mail-order drugs, especially as pro-abortion advocates
their use to “circumvent abortion restrictions” and
Women in states with a ban on ordering. These advocates rely on a lack of transparency about the side effects of the pill and hope that the women they serve will not do their own research. Hey Jane, for example,
its product as “fast, safe and affordable” – a convenient alternative to going to the clinic. Its website also states that abortion “is one of the safest medical procedures on the market.”

The industry needs to be honest: abortion pills are not an easy, safe procedure. Not for the women and certainly not for the child.

Comments are closed.